There have been some reports of a possible association between breast implants and a rare form of lymphoma (ALCL).
Approximately 170 cases have been reported globally of this rare lymphoma in women with breast implants. Greater than 10 million women worldwide have breast implants.
Risk factors may include a combination of genetic predisposition, bacterial contamination and textured implants.
Patients with seromas (a build-up of fluid under the skin) greater than 12 months after their surgery should have an ultrasound and fluid taken for testing.
In the unlikely event that you were to contract this rare form of lymphoma in the breast, treatment may include removal of the implants, chemotherapy, and radiotherapy.
While chances of cure are good there would be a remote chance of the disease spreading or not responding to treatment.
The Therapeutic Goods Administration (TGA) is the Government Body responsible for the use of all medical devices including breast implants. The TGA provides up-to-date information on its website www.tga.gov.au.
